About products, innovations and the company

EUROIMMUN’s portfolio for therapeutic drug monitoring is expanding

EUROIMMUN has been offering test systems for therapeutic drug monitoring (TDM) since 2019. Owing to the cooperation with IDS and their range of TDM products from Theradiag, we were able to ...

Immunoblots: an old friend with a new face – An interview with EUROIMMUN

Ultrafast immunofluorescence microscopy – now with 89 new products for autoimmune and infection diagnostics

First newly developed ELISA of risk class B declared IVDR-compliant

After EUROIMMUN received the required certificate for its quality management system in accordance with the new European Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR) in May of ...

Dried blood spots provide easy, reliable antibody testing

Dried blood spots (DBS) collected from the fingertip yield reliable results in analysis of anti-SARS-CoV-2 antibodies, even after prolonged storage of DBS eluates for 6 to 8 hours. This was ...

Omicron-induced T- and B-cell immunity in vaccinated and naïve individuals

A recent study has demonstrated substantial differences in SARS-CoV-2 immunity after Omicron infection in triple-COVID-19-vaccinated and antigen-naïve individuals, which may influence cross-protection ...

Schleswig-Holstein’s Minister of Economic Affairs visits EUROIMMUN

Claus Ruhe Madsen, Minister of Economic Affairs, Transport, Employment, Technology and Tourism of the German state of Schleswig-Holstein, together with Dr. Jürgen Walkenhorst and Dr. Georg Eschenburg ...

A life-saving diagnosis thanks to comprehensive antibody testing – a motivating success story

In our latest video, Mr Mende tells us how autoantibody determination completely changed his prognosis. For the past six years, Mr Mende has suffered from necrotising myositis, an autoimmune disease ...

EUROIMMUN receives IVDR certificate

Availability of EUROIMMUN products in the EU secured

On May 10, 2023, EUROIMMUN received the certificate for its quality management system according to the new European Regulation on in vitro ...

UNIQO 160 – from primary sample to final result

The UNIQO 160 embodies the next generation of fully automated systems for indirect immunofluorescence diagnostics.
What is behind it?

Back to top
Contact person on site
Please click on a country or enter yours
North America
South & Central America
Middle East & Africa


Dear Visitor,

We'd like to use Hotjar, a service that helps us improve our website based on user behavior. Hotjar uses cookies to collect data about your device and behavior. This information is stored in a pseudonymized user profile.

Neither Hotjar nor we use this information to identify individual users. For more details, see Hotjar's Privacy Policy here.

If you agree, please click "Accept". You can withdraw your consent at any time. Thank you!

Necessary Cookies OnlyAccept